Intestinal gases: influence on gut disorders and the role of dietary manipulations.


Journal

Nature reviews. Gastroenterology & hepatology
ISSN: 1759-5053
Titre abrégé: Nat Rev Gastroenterol Hepatol
Pays: England
ID NLM: 101500079

Informations de publication

Date de publication:
12 2019
Historique:
accepted: 29 07 2019
pubmed: 15 9 2019
medline: 8 2 2020
entrez: 15 9 2019
Statut: ppublish

Résumé

The inner workings of the intestines, in which the body and microbiome intersect to influence gut function and systemic health, remain elusive. Carbon dioxide, hydrogen, methane and hydrogen sulfide, as well as a variety of trace gases, are generated by the chemical interactions and microbiota within the gut. Profiling of these intestinal gases and their responses to dietary changes can reveal the products and functions of the gut microbiota and their influence on human health. Indeed, different tools for measuring these intestinal gases have been developed, including newly developed gas-sensing capsule technology. Gases can, according to their type, concentration and volume, induce or relieve abdominal symptoms, and might also have physiological, pathogenic and therapeutic effects. Thus, profiling and modulating intestinal gases could be powerful tools for disease prevention and/or therapy. As the interactions between the microbiota, chemical constituents and fermentative substrates of the gut are principally influenced by dietary intake, altering the diet, which, in turn, changes gas profiles, is the main therapeutic approach for gastrointestinal disorders. An improved understanding of the complex interactions within the intestines that generate gases will enhance our ability to prevent, diagnose, treat and monitor many gastrointestinal disorders.

Identifiants

pubmed: 31520080
doi: 10.1038/s41575-019-0193-z
pii: 10.1038/s41575-019-0193-z
doi:

Substances chimiques

Gases 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

733-747

Auteurs

Kourosh Kalantar-Zadeh (K)

School of Chemical Engineering, University of New South Wales (UNSW), Kensington, NSW, Australia. k.kalantar-zadeh@unsw.edu.au.

Kyle J Berean (KJ)

School of Chemical Engineering, University of New South Wales (UNSW), Kensington, NSW, Australia.
School of Engineering, RMIT University, Melbourne, VIC, Australia.
Atmo Biosciences, Box Hill, VIC, Australia.

Rebecca E Burgell (RE)

Department of Gastroenterology, Monash University and Alfred Health, Melbourne, VIC, Australia.

Jane G Muir (JG)

Department of Gastroenterology, Monash University and Alfred Health, Melbourne, VIC, Australia.

Peter R Gibson (PR)

Department of Gastroenterology, Monash University and Alfred Health, Melbourne, VIC, Australia. peter.gibson@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH